文献速递产科母胎医学

子痫前期与血压正常妊娠中炎症和氧化应激生物标志物的重复测量

Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies.
PubMed 文献 · Am J Obstet Gynecol · 2016-12-30

本研究基于LIFECODES前瞻性出生队列441名孕妇(子痫前期50例、血压正常391例),在妊娠中位10、18、26、35周重复测量炎症和氧化应激标志物,采用Cox比例风险模型分析其与子痫前期诊断时间的关联。调整模型中,第2次随访(中位18周)所有炎症标志物与子痫前期风险显著相关(P<.01),肿瘤坏死因子-α在4次随访中持续升高。作者认为生物标志物单独不适用于预测子痫前期,但有助于理解发病前的母体炎症特征。

要点

  • 第2次随访(中位18周)炎症标志物与子痫前期风险显著相关,风险比1.31-1.83(P<.01)。
  • 肿瘤坏死因子-α在4次随访中持续升高,风险比1.49-1.63(P<.01)。
  • 作者认为生物标志物单独不适用于预测子痫前期。

核心结论

  • 子痫前期与血压正常妊娠的炎症和氧化应激标志物在妊娠期呈现不同模式,差异最早可于10周出现。
  • 妊娠中期开始似乎是测量这些生物标志物特别重要的时间点。
  • 生物标志物单独不适用于预测子痫前期,但有助于理解发病前的母体炎症特征,并可能用于进一步理解潜在预防措施。

研究设计与样本

  • 研究为LIFECODES前瞻性出生队列分析,纳入441名孕妇,其中子痫前期50例、血压正常妊娠391例。
  • 参与者在妊娠期4个时间点(中位10、18、26、35周)提供尿液和血浆样本,检测氧化应激和炎症标志物组合。
  • 采用Cox比例风险模型,基于子痫前期诊断时间计算各次随访生物标志物浓度与子痫前期风险的关联。

主要发现

  • 调整模型中,第2次随访(中位18周)测量的所有炎症标志物与子痫前期风险显著相关(P<.01),风险比1.31-1.83(对应生物标志物四分位距增加)。
  • 该时间点C反应蛋白、白细胞介素-1β、-6、-10及氧化应激标志物8-异前列腺素的风险比相对其他时间点最高,8-异前列腺素风险比1.68(95%CI 1.14-2.48)。
  • 肿瘤坏死因子-α在4次随访中风险比持续升高(风险比1.49-1.63,P<.01)。
  • 敏感性分析中,这些关联在通常子痫前期风险较高的组内(非裔美国母亲、妊娠早期体重指数较高者、早产妊娠)出现衰减。

临床怎么用

  • 作者认为生物标志物单独不适用于预测子痫前期。
  • 作者认为这些数据有助于理解子痫前期发病前的母体炎症特征,并可能用于进一步理解潜在预防措施。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preeclampsia is a prevalent and enigmatic disease, in part characterized by poor remodeling of the spiral arteries. However, preeclampsia does not always clinically present when remodeling has failed to occur. Hypotheses surrounding the "second hit" that is necessary for the clinical presentation of the disease focus on maternal inflammation and oxidative stress. Yet, the studies to date that have investigated these factors have used cross-sectional study designs or small study populations. OBJECTIVE: In the present study, we sought to explore longitudinal trajectories, beginning early in gestation, of a panel of inflammation and oxidative stress markers in women who went on to have preeclamptic or normotensive pregnancies. STUDY DESIGN: We examined 441 subjects from the ongoing LIFECODES prospective birth cohort, which included 50 mothers who experienced preeclampsia and 391 mothers with normotensive pregnancies. Participants provided urine and plasma samples at 4 time points during gestation (median, 10, 18, 26, and 35 weeks) that were analyzed for a panel of oxidative stress and inflammation markers. Oxidative stress biomarkers included 8-isoprostane and 8-hydroxydeoxyguanosine. Inflammation biomarkers included C-reactive protein, the cytokines interleukin-1β, -6, and -10, and tumor necrosis factor-α. We created Cox proportional hazard models to calculate hazard ratios based on time of preeclampsia diagnosis in association with biomarker concentrations at each of the 4 study visits. RESULTS: In adjusted models, hazard ratios of preeclampsia were significantly (P<.01) elevated in association with all inflammation biomarkers that were measured at visit 2 (median, 18 weeks; hazard ratios, 1.31-1.83, in association with an interquartile range increase in biomarker). Hazard ratios at this time point were the most elevated for C-reactive protein, for interleukin-1β, -6, and -10, and for the oxidative stress biomarker 8-isoprostane (hazard ratio, 1.68; 95% confidence interval, 1.14-2.48) compared to other time points. Hazard ratios for tumor necrosis factor-α were consistently elevated at all 4 of the study visits (hazard ratios, 1.49-1.63; P<.01). In sensitivity analyses, we observed that these associations were attenuated within groups typically at higher risk of experiencing preeclampsia, which include African American mothers, mothers with higher body mass index at the beginning of gestation, and pregnancies that ended preterm. CONCLUSIONS: This study provides the most robust data to date on repeated measures of inflammation and oxidative stress in preeclamptic compared with normotensive pregnancies. Within these groups, inflammation and oxidative stress biomarkers show different patterns across gestation, beginning as early as 10 weeks. The start of the second trimester appears to be a particularly important time point for the measurement of these biomarkers. Although biomarkers alone do not appear to be useful in the prediction of preeclampsia, these data are useful in understanding the maternal inflammatory profile in pregnancy before the development of the disease and may be used to further develop an understanding of potentially preventative measures.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Ferguson KK, Meeker JD, McElrath TF, et al. Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies. Am J Obstet Gynecol. 2016. PMID: 28043842. doi:10.1016/j.ajog.2016.12.174

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。